Comprehensive bibliography on the use of thromboelastography in COVID-19:

ARTICLE TITLE

JOURNAL

AUTHORS

Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated with adult respiratory distress syndrome (ARDS)?

J Trauma Acute Care Surg. 2020 Jun;88(6):713-714

Moore HB, Barrett CD, Moore EE, McIntyre RC, Moore PK, Talmor DS, Moore FA, Yaffe MB

Hypercoagulability of COVID-19 Patients in Intensive Care Unit. A Report of Thromboelastography Findings and Other Parameters of Hemostasis

J Thromb Haemost. 2020 Jul;18(7):1738-1742

Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A

Coagulopathy in COVID-19: Review and Recommendations

https://www.facs.org/-/media/files/covid19/umiami_study_uses_of_coagulopathy.ashx

Brandon M. Parker

Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA):A case series

J Trauma Acute Care Surg. 2020 Sep;89(3):453-457

Barrett CD, Oren-Grinberg A, Chao E, Moraco, AH, Martin, MJ, Reddy SH, Ilg AM, Jhunjhunwala R, Uribe M, Moore HB, Moore EE, Baedorf-Kassis EN, Krajewski ML, Talmor DS, Shaefi S, Yaffe MB

Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection

J Am Coll Surg. 2020 Aug;231(2):193-203.e1

Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, Nydam TL, Moore PK, McIntyre RC

Technologies to Optimize the Care of Severe COVID-19 Patients for Healthcare Providers Challenged by Limited Resources

Anesth Analg. 2020 Aug;131(2):351-364

Rubulotta F, Soliman-Aboumarie H, Filbey K, Geldner G, Kuck K, Ganau M, Hemmerling TM

Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019

Crit Care Med. 2020 Sep;48(9):e783-e790

Maatman TK, Jalali F, Feizpour C, Douglas 2nd A, McGuire SP, Kinnaman G, Hartwell JL, Maatman BT, Kreuttz RP, Kapoor R, Rahman O, Zyromski NJ, Meagher AD

Global haemostatic tests in rapid diagnosis and management of COVID‑19 associated coagulopathy in acute limb ischaemia

J Thromb Thrombolysis. 2020 Aug;50(2):292-297

Fan BE, Chia YW, Sum CLL, Kuperan P, Chan SSW, Ling LM, Tan GWL, Goh SSN, Wong LH, Lim SP, Lim KGE, Ang MK, Lau SL, Ong KH, Ng J

Thromboelastographic results and hypercoagulability syndrome in patients with coronavirus disease 2019  who are critically ill

JAMA Network Open. 2020;3(6):e2011192. doi:10.1001/jamanetworkopen.2020.11192

Mortus JR, Manek SE, Brubaker LS, Loor M, Cruz MA, Trautner BW, Rosengart TK

COVID-19 associated coagulopathy and inflammatory response: what do we know already and what are the knowledge gaps?

Anesthesia & Analgesia: November 2020 - Volume 131 - Issue 5 - p 1324-1333  doi:10.1213/ANE.000000000000514

Gorlinger K, Dirkmann D, Gandhi A, Simioni P

A proposal for staging COVID-19 coagulopathy

Res Pract Thromb Haemost. 2020;4:731-736

Thachil J, Cushman M, & Srivastava A

Thromboelastography profiles of critically ill patients with coronavirus disease 2019

Crit Care Med 2020 Jun 26;10.

Yuriditsky E, Horowitz JM, Brosnahan S, McVoy L, Berger JS

Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019

Letter to the editor, Thromb Res. 2020; 195: 69-71.

Hightower S, Elllis H, Collen J, Ellis J, Grasso I, Roswarski J, Cap AR, Chung K, Prescher L, Kavanaugh M, Brown T, Nau M, Clark P

Pulmonary angiopathy in severe COVID-19: Physiologic, imaging and hematologic observations

Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699

Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, Singh S, Thakuria L, Trenfield S, Trimlett R, Weaver C, Wort SJ, Xu T, Padley SPG, Devaraj A, Desai SR

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

Thromb Haemost 2020; 120(11): 1594-1596     DOI:10.1055/s-0040-171421

Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA

Anti Xa activity after high dose LMWH thrombosis prophylaxis in COVID 19 patients at the intensive care unit

Thromb Res. 2020 Jul 22;196:1-3. doi:10.1016/j.thromres.2020.07.035.

Vlot EA, Van den Dool EJ, Hackeng CM, Sohne M, Noordzij EJ, Van Dongen EPA,

Disease Severity Assessed By Thromboelastography In A Minority Population With Covid-19

https://www.ahajournals.org/doi/10.1161/circ.142.suppl_3.16780  

Bliden K, Rout A, Chaudhary R, Barnes J, Tantry U, Gurbel PA

Heightened Platelet Function: An Unrecognized Component Of The Covid Hypercoagulability State

https://www.ahajournals.org/doi/10.1161/circ.142.suppl_3.16676  

Bliden K, Rout A, Chaudhary R, Barnes J, Tantry U, Gurbel PA

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients

J Crit Care. 2020 Sep 3;60:249-252.  doi:10.1016/j.jcrc.2020.08.026.

Stattin K, Lipcsey M, Andersson H, Pontein E, Anderberg S, Gradin A, Larsson A, Lubenow N, von Seth M, Rubertsson S, Hultstrom M, Frithiof R

Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study

Crit Care. 2020 Sep 18;24(1):561.  doi:10.1186/s13054-020-03260-3

Shah A, Donovan K, McHugh A, Pandey M, Aaron L, Bradbury CA, Stanworth SJ, Alikhan R, Von Kier S, Maher K, Curry N, Shapiro S, Rowland MJ, Thomas M, Mason R, Holland M, Holmes T, Ware M,, Gurney S, and McKechnie SR

Usefulness of combining D-dimers with thromboelastography

J Am Coll Surg. 2020 Sep 17;S1072-7515(20)30550-0.  doi:10.1016/j.jamcollsurg.2020.07.004.

Thachil J

Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients

Crit Care Explor. 2020 Sep 15;2(9):e0192

Sadd C, Rowe T, Nazeef M, Kory P, Sultan S, Faust H

Thromboelastography findings in critically ill COVID-19 patients

J Thromb Thrombolysis. 2020 Oct 4;1-5.

Salem N, Atallah B, El Nekidy WS, Sadik ZG, Park WM, Mallat J

COVID-19 infection-related coagulopathy and viscoelastic methods: A paradigm for their clinical utility in critical illness

Diagnostics (Basel). 2020 Oct 14;10(10):E817.

Tsantes AE, Tsantes AG, Kokoris SI, Bonovas S, Frantzeskaki F, Tsanfaris I, Kopterides T

Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: Implications for clinical practice and future investigations

Crit Care 24, 559 (2020). doi.org/10.1186/s13054-020-03273-y

Flaczyk A., Rosovsky R.P., Reed C.T., Bankhead-Kendall B.K., Bittner E.A., Chang M.G

Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review

Res Pract Thromb Haemost. 2020;4:524–531 DOI:10.1002/rth2.12357

Barrett C.D., Moore H.B., Moore E.E., McIntyre R.C., Moore P.K., Burke J., Hua F., Apgar J., Talmor D.S., Sauaia A., Liptzin D.R., Veress L.A., Yaffe M.B.

Understanding the COVID -19 coagulopathy spectrum

Anaesthesia. 2020 May 21 : 10.1111/anae.15141. doi:10.1111/anae.15141

Thacil J and Agarwal S

Viscoelastic Tests in the Evaluation of Haemostasis Disturbances in SARS-CoV2 Infection

Acta Med Port 2021 Jan;34(1):44-55. doi.org/10.20344/amp.14784

Rodrigues A, Sevivas TS, Pereira CL, Caiado A, Nunes AR

Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19

Int J Mol Sci. 2020 Nov 3;21(21):E8234. 

Venter C, Bezuidenhout JA, Laubscher GJ, Lourens PJ, Sttenkamp J, Kell DB, Pretorius E

Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19

Mil Med Res. 2020 Apr 20;7(1):19.

Song J.-C.,  Wang G.,  Zhang W.,  Zhang Y., Li W.-Q., Zhou Z.

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations

EClinicalMedicine The Lancet. Volumes 29-30, December 2020: 100647

Chaudhary R, Bliden KP, Kreutz RP, Jeong YH, Tantry US, Levy JH, Gurbel PA

Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019-Related Coagulopathy

Crit Care Explor. 2020 Dec 21;2(12):e0287.

Hranjec T, Estreicher M, Rogers B, Kohler L, Solomon R, Hennessy S, Cibulas M, Hurst D, Hegazy M, Lee J, Perez D, Doctor N, Kiffin C, Pigneri D, LaGuardia H, Shaw K, Arenas J, Rosenthal A, Katz RS, Sawyer RG, Pepe PE.

Disturbances of the hemostasis system and expression of inflammatory reaction in patients with new coronaviral pneumonia

Klin Lab Diagn. 2020 Dec 29;65(12):744-749.

Presnyakova MV, Galova EA, Sosnina LN, Popovicheva AN, Lyubavina NA, Kostina OV, Kuznetsova VL, Karyakin NN

Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study

Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12466-12479. doi:10.26355/eurrev_202012_24043

Bocci MG, Maviglia R, Consalvo LM, Grieco DL, Montini L, Mercurio G, Nardi G, Pisapia L, Cutuli SL, Biasucci DG, Gori C, Rosenkranz R, De Candia E, Carelli S, Natalini D, Antonelli M, Franceschi F

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

Nat Rev Cardiol. 2020 Nov 19;1-16.  doi:10.1038/s41569-020-00469-1.

Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J.

Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series

Eur Heart J Case Rep. 2020 Dec 12;4(6):1-7. 

Castro-Verdes M, Gkouma A, Wort J, Ridge C, Mirsadraee S, Padley S, Sheikh A, Singh S

Source: PUBMED search using the following terms: "Covid-19" OR "Coronavirus" OR "sarscov2") AND ("viscoelastic" OR "VHA" OR "TEG" OR "thromboelastography" OR "thromboelastographic" OR   "thromboelastograph" OR "thrombelastograph")

© 2021 Haemonetics Corporation. Haemonetics, and TEG,are trademarks or registered trademarks of Haemonetics Corporation in the USA, other countries or both. 02.2021 USA. COL-COPY-001499-US(AA)